BWV News and Press, Blue Water Vaccines Inc. From 04/11/22

Blue Water Vaccines (BWV) stock hit a new 52-week low Monday morning in the wake of last week's sell-off. Shares of the universal flu vaccine developer recently changed hands at $8.67, down 20%, at approximately 10:45 p.m. ET. The stock hit a 52-week low of $8.52 mid-morning after opening at ...

BWV-101 - Universal Influenza Program: Developing a novel vaccine to protect against all influenza strains using groundbreaking mathematical models and research CINCINNATI, April 11, 2022 (GLOBE NEWSWIRE) -- Blue Water Vaccines Inc. (“BWV” or “Blue Water...

Blue Water Vaccines (BWV) stock was up 11% midday Friday after plunging 83% on Thursday. Shares of the influenza vaccine developer recently changed hands at $11.31, up 11%, at approximately 1:00 p.m. ET. The stock opened at $12.68, hitting a high of $14.14 before sliding to a low of $10.75 in...

NEW YORK, April 08, 2022 (GLOBE NEWSWIRE) -- Wall Street Reporter, the trusted name in financial news since 1843, has published reports on the latest comments and insights from CEOs of: Sunshine Biopharma, Inc. (NASDAQ: SBFM), PharmaDrug (OTC: LMLLF) (CSE: PHRX), Blue Water Vaccines (NASD...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Get ready for another busy day of trading with our breakdown of the biggest pre-market stock movers for Friday! Source: oneinchpunch/Shutterstock.com A ratio change, clinical trial results, a pilot program, and more...

Blue Water Vaccines (BWV) stock plunged 83% on Thursday, but is still up 13% from its initial public offering price. Shares of the influenza vaccine developer closed at $10.17, down 83%. The stock opened at $57.88. Blue Water held its initial public offering on Feb. 18. The company raised $20...

Blue Water Vaccine (BWV) stock plunged 67% on Thursday in midday action, but is still up 115% from its initial public offering price. Shares of the influenza vaccine developer recently changed hands at $19.39, down 67%, at approximately 12:15 p.m. ET. Blue Water held its initial public offeri...

Inflation expectations have kept the Federal Reserve center stage as they commenced their interest rate rising cycle in March. The war in Ukraine and Omicron’s spread in China impacted inflation and supply chains differently, but both delay supply chain normalization. Regar...

Pick any barometer of costs these days, and the story is the same: Prices are up - and in a dramatic fashion. The first thing that jumps out is the dismal performance of most asset classes during periods of low growth and high inflation - otherwise known as stagflation. A solid fo...

Blue Water Vaccines has exclusive, global licensing rights to Cincinnati Children’s Hospital Medical Center’s novel virus-like particle (VLP) vaccine platform. The data supports BWV’s ongoing development of a transformational universal influenza vaccine, as well...